| Dr Karen Bat-sheba Saks, MD | |
|
9701 Sw Barnes Rd Ste 300, Portland, OR 97225-6689 | |
| (503) 297-8081 | |
| (503) 292-6601 |
| Full Name | Dr Karen Bat-sheba Saks |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 13 Years |
| Location | 9701 Sw Barnes Rd Ste 300, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306136502 | NPI | - | NPPES |
| 2025126 | Medicaid | WA | |
| 500654961 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD179839 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Clinic Pc | 2860390408 | 319 |
News Archive
Kessler Foundation researchers have demonstrated changes in the functional connectivity within the 'fatigue network' in response to cognitive fatigue.
African Americans who believe their church is responsible for promoting health in their members and the community are also more willing to attend church-based health fairs, according to a new study in Health Promotion Practice.
In this context, Josjan Zijlmans and Lorynn Teela et al. investigate the mental and social health of children and adolescents with pre-existing mental or somatic problems (pediatric or psychiatric) during the COVID-19 pandemic lockdown.
An unusual and uncommon psychiatric disorder that compels people to pull out their hair is now thought to be caused by a mutant gene.
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that the independent Data Monitoring Committee (DMC) of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis as specified by the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to full patient enrollment and completion.
› Verified 4 days ago
| Entity Name | Oregon Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
Kessler Foundation researchers have demonstrated changes in the functional connectivity within the 'fatigue network' in response to cognitive fatigue.
African Americans who believe their church is responsible for promoting health in their members and the community are also more willing to attend church-based health fairs, according to a new study in Health Promotion Practice.
In this context, Josjan Zijlmans and Lorynn Teela et al. investigate the mental and social health of children and adolescents with pre-existing mental or somatic problems (pediatric or psychiatric) during the COVID-19 pandemic lockdown.
An unusual and uncommon psychiatric disorder that compels people to pull out their hair is now thought to be caused by a mutant gene.
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that the independent Data Monitoring Committee (DMC) of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis as specified by the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to full patient enrollment and completion.
› Verified 4 days ago
| Entity Name | University Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
Kessler Foundation researchers have demonstrated changes in the functional connectivity within the 'fatigue network' in response to cognitive fatigue.
African Americans who believe their church is responsible for promoting health in their members and the community are also more willing to attend church-based health fairs, according to a new study in Health Promotion Practice.
In this context, Josjan Zijlmans and Lorynn Teela et al. investigate the mental and social health of children and adolescents with pre-existing mental or somatic problems (pediatric or psychiatric) during the COVID-19 pandemic lockdown.
An unusual and uncommon psychiatric disorder that compels people to pull out their hair is now thought to be caused by a mutant gene.
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that the independent Data Monitoring Committee (DMC) of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis as specified by the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to full patient enrollment and completion.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen Bat-sheba Saks, MD 541 Ne 20th Ave Ste 225, Portland, OR 97232-2895 Ph: (503) 963-2801 | Dr Karen Bat-sheba Saks, MD 9701 Sw Barnes Rd Ste 300, Portland, OR 97225-6689 Ph: (503) 297-8081 |
News Archive
Kessler Foundation researchers have demonstrated changes in the functional connectivity within the 'fatigue network' in response to cognitive fatigue.
African Americans who believe their church is responsible for promoting health in their members and the community are also more willing to attend church-based health fairs, according to a new study in Health Promotion Practice.
In this context, Josjan Zijlmans and Lorynn Teela et al. investigate the mental and social health of children and adolescents with pre-existing mental or somatic problems (pediatric or psychiatric) during the COVID-19 pandemic lockdown.
An unusual and uncommon psychiatric disorder that compels people to pull out their hair is now thought to be caused by a mutant gene.
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that the independent Data Monitoring Committee (DMC) of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis as specified by the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to full patient enrollment and completion.
› Verified 4 days ago
Salona Shrestha, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |